title: Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies.
authors.forename: John R
authors.initials: JR
authors.lastname: Hughes
authors.forename: Neal
authors.initials: N
authors.lastname: Benowitz
authors.forename: Dorothy
authors.initials: D
authors.lastname: Hatsukami
authors.forename: Robin J
authors.initials: RJ
authors.lastname: Mermelstein
authors.forename: Saul
authors.initials: S
authors.lastname: Shiffman
mesh_terms: D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D005731:Ganglionic Stimulants / Q000008:administration & dosage / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000627:therapeutic use; D016540:Smoking Cessation; D014029:Tobacco Use Disorder / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D005731:Ganglionic Stimulants; D009538:Nicotine